← Embecta Corp.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|
| Revenues | $1.1b | $1.2b | $1.1b | $1.1b | $1.1b | $1.1b | |
| Gross Profit | $762.6m | $800.4m | $774.9m | $749.9m | $735.2m | $676.8m | |
| Other operating expenses | $0 | $4.8m | $44.7m | $99.4m | $124.5m | $65.4m | |
| Total Operating Expenses | $276.1m | $308.4m | $465.3m | $528.4m | $568.4m | $434.7m | |
| Operating Income | $486.5m | $492.0m | $309.6m | $221.5m | $166.8m | $242.1m | |
| Income tax provision (benefit) | $58.2m | $80.1m | $33.0m | $35.3m | ($34.1m) | $40.9m | |
| Income Before Income Taxes | $485.8m | $494.9m | $256.6m | $105.7m | $44.2m | $136.3m | |
| Net Income | $427.6m | $414.8m | $223.6m | $70.4m | $78.3m | $95.4m | |
| Basic (in dollars per share) | $7.50 | $7.28 | $3.92 | $1.23 | $1.36 | $1.64 | |
| Diluted (in dollars per share) | $7.50 | $7.28 | $3.89 | $1.22 | $1.34 | $1.62 | |
| Cost of products sold | $322.9m | $364.9m | $354.6m | $370.9m | $387.9m | $403.6m | |
| Selling and administrative expense | $214.7m | $240.3m | $294.8m | $341.3m | $365.1m | $332.0m | |
| Research and development expense | $61.4m | $63.3m | $66.9m | $85.2m | $78.8m | $37.3m | |
| Impairment expense | $0 | $0 | $58.9m | $2.5m | $0 | $0 | |
| Interest expense, net | $0 | $0 | ($46.2m) | ($107.0m) | ($112.3m) | ($107.3m) | |
| Other income (expense), net | ($700k) | $2.9m | ($6.8m) | ($8.8m) | ($10.3m) | $1.5m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.